Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

181.96
-2.0201-1.10%
Volume:83.60K
Turnover:15.21M
Market Cap:3.58B
PE:80.16
High:185.18
Open:183.23
Low:179.46
Close:183.98
52wk High:212.49
52wk Low:93.58
Shares:19.68M
Float Shares:19.16M
Volume Ratio:0.94
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.27
EPS(LYR):-0.2204
ROE:5.42%
ROA:1.48%
PB:3.77
PE(LYR):-825.41

Loading ...

Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 18, 2025

Major Issues Report

Form 8-K - Current report
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2025

Major Issues Report

Form 8-K - Current report
Sep 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2025

Major Issues Report

Form 8-K - Current report
Aug 11, 2025

Major Issues Report

Form 8-K - Current report
Aug 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Aug 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities